Collaboration agreement with AbbVie (Tables)

12 Months Ended

Dec. 31, 2024

Collaboration agreement with AbbVie

Summarizes the change in deferred revenue

The following table summarizes the change in deferred revenue (in thousands):

	Year Ended December 31,
	2024		2023
Beginning balance	$	15,982	$	—
Deferral of revenue		—		30,000
Recognition of revenue		(9,041)		(14,018)
Balance at the end of the period	$	6,941	$	15,982